Kromek Group PLC Kromek enters agreement with Smiths Detection Inc. (6042R)
July 07 2022 - 2:00AM
UK Regulatory
TIDMKMK
RNS Number : 6042R
Kromek Group PLC
07 July 2022
7 July 2022
Kromek Group plc
("Kromek" or the "Group")
Kromek enters agreement with Smiths Detection Inc.
Agreement to deliver radiation detection equipment to North
& South America
Kromek Group plc, a leading developer of radiation and
bio-detection technology solutions for the advanced imaging and
CBRN detection segments, announces that it has entered into a
distribution agreement with Smiths Detection Inc. ("Smiths"), a
global leader in threat detection and security screening
technologies.
Under the terms of the agreement, Smiths will distribute the
Group's wearable radiation detection and identification solutions
to North and South American markets. Smiths will be focused on
marketing and distributing Kromek's D3 and D5 series of wearable
radiation detectors, which are designed to enable first responders,
armed forces, border security and other CBRN experts to detect
radiological threats such as dirty bombs, radioactive contamination
and smuggling of radioactive substances.
Smiths Detection, part of Smiths Group, is a global leader in
threat detection and screening technologies for aviation, ports and
borders, defence and urban security markets. Its experience and
history across more than 40 years at the frontline, enables Smiths
Detection to deliver the solutions needed to protect society from
the threat and illegal passage of explosives, prohibited weapons,
contraband, toxic chemicals and narcotics.
Dr Arnab Basu, Chief Executive Officer of Kromek, said:
"We are delighted to partner with Smiths Detection, which has
been at the forefront of providing solutions needed to protect
society for over four decades. Our wearable D3 and D5 family of
products are closely aligned to the needs of Smiths Detection's
customer base and complement their existing product offering. We
look forward to working with Smiths Detection to deliver our
solutions to customers across North and South America."
For further information, please contact:
Kromek Group plc
Arnab Basu, CEO
Paul Farquhar, CFO +44 (0)1740 626 060
finnCap Ltd (Nominated Adviser and Broker)
Geoff Nash/Kate Bannatyne/George Dollemore
- Corporate Finance +44 (0)20 7220 0500
Tim Redfern/Charlotte Sutcliffe - ECM
Luther Pendragon (Financial PR)
Harry Chathli/Claire Norbury +44 (0)20 7618 9100
About Kromek Group plc
Kromek Group plc is a leading developer of radiation detection
and bio-detection technology solutions for the advanced imaging and
CBRN detection segments. Headquartered in County Durham, UK, Kromek
has manufacturing operations in the UK and US, delivering on the
vision of enhancing the quality of life through innovative
detection technology solutions.
The advanced imaging segment comprises the medical (including CT
and SPECT), security and industrial markets. Kromek provides its
OEM customers with detector components, based on its core cadmium
zinc telluride (CZT) platform, to enable better detection of
diseases such as cancer and Alzheimer's, contamination in
industrial manufacture and explosives in aviation settings.
In CBRN detection, the Group provides nuclear radiation
detection solutions to the global homeland defence and security
market. Kromek's compact, handheld, high-performance radiation
detectors, based on advanced scintillation technology, are
primarily used to protect critical infrastructure and urban
environments from the threat of 'dirty bombs'.
The Group is also developing bio-security solutions in the CBRN
detection segment. These consist of fully automated and autonomous
systems to detect a wide range of airborne pathogens.
Kromek is listed on AIM, a market of the London Stock Exchange,
under the trading symbol 'KMK'.
Further information is available at www.kromek.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
AGRDBGDRRBGDGDL
(END) Dow Jones Newswires
July 07, 2022 02:00 ET (06:00 GMT)
Kromek (LSE:KMK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kromek (LSE:KMK)
Historical Stock Chart
From Jul 2023 to Jul 2024